Keyphrases
Nasopharyngeal Carcinoma
100%
Therapeutic Candidates
100%
Centipeda Minima
100%
Arnicolide D
100%
Nasopharyngeal Carcinoma Cells
33%
Molecular Mechanism
22%
Further Development
11%
Inhibitory Effect
11%
Apoptosis Induction
11%
Cdc2
11%
Cell Viability
11%
Cell Apoptosis
11%
Traditional Chinese Medicine
11%
Cyclin D3
11%
Dynamic Change
11%
Cell Cycle Regulation
11%
Southeast China
11%
Phosphoinositide 3-kinase (PI3K)
11%
Anticancer Effect
11%
CNE2
11%
Cell Cycle Arrest
11%
Caspase Pathway
11%
Drug Development
11%
C666-1 Cells
11%
Cleaved caspase-9
11%
High Mortality
11%
P-STAT3
11%
AKT1
11%
STAT3 Signaling Pathway
11%
Bcl-2 Expression
11%
Mammalian Target of Rapamycin (mTOR)
11%
High Morbidity
11%
PI3K-AKT-mTOR Pathway
11%
CNE-1
11%
Cyclin B1
11%
Sesquiterpene Lactones
11%
Cyclin-dependent Kinase 6 (CDK6)
11%
Cleaved PARP
11%
Racial Bias
11%
Geographic Bias
11%
Pharmacology, Toxicology and Pharmaceutical Science
Nasopharynx Carcinoma
100%
Protein Kinase B
33%
Drug Development
16%
Cell Viability
16%
Traditional Chinese Medicine
16%
Malignant Neoplasm
16%
Lead Compound
16%
Cancer Mortality
16%
Cyclin D3
16%
Caspase 9
16%
Cyclin B1
16%
Base
16%
Caspase
16%
Sesquiterpene Lactone
16%